Health & Nutrition

bg
A mom and tech entrepreneur building AI advocate for rare-disease families like hers

A mom and tech entrepreneur building AI advocate for rare-disease...

AI-powered healthcare startup Citizen Health is using the technology to focus on...

bg
Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer

Former Sen. Ben Sasse shines the spotlight on a possible...

Former Sen. Ben Sasse is taking Revolution Medicines' daraxonrasib, which has shown...

bg
CNBC Cures: A father and a doctor on how raising a child with Angelman syndrome changed him

CNBC Cures: A father and a doctor on how raising a child...

A doctor reflects on how raising a son with Angelman syndrome reshaped his family,...

bg
Why Cooling Potatoes Lowers Their Glycemic Load

Why Cooling Potatoes Lowers Their Glycemic Load

If you eat potatoes when they’re cold, as in potato salad, or chilled and reheated,...

bg
Explore NutritionFacts.org Resources

Explore NutritionFacts.org Resources

NutritionFacts.org has a wide range of resources to help you on your journey to...

bg
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

Novo Nordisk's explosive Wegovy pill launch draws a new...

CNBC spoke with five U.S. patients who recently started the pill following its launch...

bg
FDA declines to issue specific guidance on health programs' foreign drug imports

FDA declines to issue specific guidance on health programs'...

A CNBC investigation revealed the proliferation of AFPs, which import prescription...

bg
Do Potatoes Shorten Your Life?

Do Potatoes Shorten Your Life?

Do potato eaters live longer or shorter lives than non-potato eaters? Is there a...

bg
Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Stocks soar on hopes of Iran war resolution — plus, Lilly...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon...

bg
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Lilly to spend up to $7.8 billion to acquire Centessa,...

Centessa is one of several companies working on a new class of drugs to treat narcolepsy,...